# BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer

> **NCT01679405** · PHASE1 · TERMINATED · sponsor: **Johannes Gutenberg University Mainz** · enrollment: 9 (actual)

## Conditions studied

- Metastatic Disease

## Interventions

- **DRUG:** BIBW 2992

## Key facts

- **NCT ID:** NCT01679405
- **Lead sponsor:** Johannes Gutenberg University Mainz
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** No sufficient clinical or molecular signals for efficacy were observed.
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01679405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01679405, "BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01679405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*